Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population

European Journal of Immunology

Volumn 40, Issue 5, 2010, Pages 1428-1439

  Marquardt, Nicole ^a   Wilk, Esther ^a   Pokoyski, Claudia ^a   Schmidt, Reinhold E ^a   Jacobs, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cellular immunology; Innate immunity; NK cells

Indexed keywords

CD27 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; LYSINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL3 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; IONOMYCIN; MESSENGER RNA; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL POPULATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; IN VITRO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; SECRETION; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD56; BIOLOGICAL MARKERS; CHEMOKINE CCL3; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKINS; IONOMYCIN; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; RECEPTORS, CXCR3; RNA, MESSENGER; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951723662     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940056     Document Type: Article

References (47)

1. Assarsson, E., Kambayashi, T., Persson, C. M., Ljunggren, H. G. and Chambers, B. J., 2B4 co-stimulation: NK cells and their control of adaptive immune responses. Mol. Immunol. 2005. 42: 419-423.
2. Blanca, I. R., Bere, E. W., Young, H. A. and Ortaldo, J. R., Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+B cells. J. Immunol. 2001. 167: 6132-6139.
3. Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M. C. and Moretta, A., Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 2006. 214: 219-228.
4. Ralainirina, N., Poli, A., Michel, T., Poos, L., Andres, E., Hentges, F. and Zimmer, J., Control of NK cell functions by CD4+CD25+regulatory T cells. J. Leukoc. Biol. 2007. 81: 144-153.
5. Schierloh, P., Aleman, M., Yokobori, N., Alves, L., Roldan, N., Abbate, E., del C Sasiain, M. and de la Barrera, S., NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Immunology 2005. 116: 541-552. (Pubitemid 41713185)
6. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K., Doherty, J. M. et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722-725.
7. Walzer, T., Jaeger, S., Chaix, J. and Vivier, E., Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr. Opin. Immunol. 2007. 19: 365-372.
8. Makrigiannis, A. P. and Anderson, S. K., Regulation of natural killer cell function. Cancer Biol. Ther. 2003. 2: 610-616.
9. Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A. and Ritz, J., Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 1990. 171: 1509-1526.
10. Deniz, G., Akdis, M., Aktas, E., Blaser, K. and Akdis, C. A., Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. Eur. J. Immunol. 2002. 32: 879-884.
11. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191. (Pubitemid 20010143)
12. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
13. Jacobs, R., Stoll, M., Stratmann, G., Leo, R., Link, H. and Schmidt, R. E., CD16-CD56+Natural Killer cells after bone marrow transplantation. Blood 1992. 79: 3239-3244.
14. Wilk, E., Kalippke, K., Buyny, S., Schmidt, R. E. and Jacobs, R., New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology 2008. 213: 271-283.
15. Jacobs, R., Hintzen, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K. W. and Schmidt, R. E., CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J Immunol 2001. 31: 3121-3127. (Pubitemid 32994564)
16. Anfossi, N., Andre, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V. et al., Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006. 25: 331-342. (Pubitemid 44224147)
17. Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G. and Moretta, L., NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 2008. 15: 226-233.
18. Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 1455-1462. (Pubitemid 38116788)
19. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D. et al., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006. 12: 1065-1074.
20. Anne, C. B., van den Heuvel, M. J., Borzychowski, A. M. and Tayade, C., Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol. Rev. 2006. 214: 161-185.
21. Blasius, A. L., Barchet, W., Cella, M. and Colonna, M., Development and function of murine B2201CD11c1NK1.11cells identify them as a subset of NK cells. J. Exp. Med. 2007. 204: 2561-2568.
22. Vosshenrich, C. A., Garcia-Ojeda, M. E., Samson-Villeger, S. I., Pasqualetto, V., Enault, L., Richard-Le Goff, O., Corcuff, E. et al., A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 2006. 7: 1217-1224.
23. Hayakawa, Y. and Smyth, M. J., CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006. 176: 1517-1524. (Pubitemid 43134295)
24. Takeda, K., Oshima, H., Hayakawa, Y., Akiba, H., Atsuta, M., Kobata, T., Kobayashi, K. et al., CD27-mediated activation of murine NK cells. J. Immunol. 2000. 164: 1741-1745.
25. Vossen, M. T., Matmati, M., Hertoghs, K. M., Baars, P. A., Gent, M. R., Leclercq, G., Hamann, J. et al., CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets. J. Immunol. 2008. 180: 3739-3745.
26. Silva, A., Andrews, D. M., Brooks, A. G., Smyth, M. J. and Hayakawa, Y., Application of CD27 as a marker for distinguishing human NK cell subsets. Int. Immunol. 2008. 20: 625-630.
27. Martin-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A. and Sallusto, F., Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004. 5: 1260-1265.
28. Wendel, M., Galani, I. E., Suri-Payer, E. and Cerwenka, A., Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res. 2008. 68: 8437-8445.
29. Wendt, K.,Wilk, E., Buyny, S., Buer, J., Schmidt, R. E. and Jacobs, R., Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J. Leukoc. Biol. 2006. 80: 1529-1541.
30. Kim, S., Iizuka, K., Kang, H. S., Dokun, A., French, A. R., Greco, S. and Yokoyama, W. M., In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 2002. 3: 523-528.
31. Wendt, K., Wilk, E., Buyny, S., Schmidt, R. E. and Jacobs, R., Interleukin-21 differentially affects human natural killer cell subsets. Immunology 2007. 122: 486-495. (Pubitemid 350075955)
32. Yu, J., Wei, M., Mao, H., Zhang, J., Hughes, T., Mitsui, T., Park, I. K. et al., CD94 defines phenotypically and functionally distinct mouse NK cell subsets. J. Immunol. 2009. 183: 4968-4974.
33. Farag, S. S. and Caligiuri, M. A., Human natural killer cell development and biology. Blood Rev. 2006. 20: 123-137. (Pubitemid 43786166)
34. Katchar, K., Soderstrom, K., Wahlstrom, J., Eklund, A. and Grunewald, J., Characterisation of natural killer cells and CD56+T-cells in sarcoidosis patients. Eur. Respir. J. 2005. 26: 77-85.
35. Clausen, J., Vergeiner, B., Enk, M., Petzer, A. L., Gastl, G. and Gunsilius, E., Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 2003. 207: 85-93. (Pubitemid 36367381)
36. Lima, M., Teixeira, M. A., Queiros, M. L., Leite, M., Santos, A. H., Justica, B. and Orfao, A., Immunophenotypic characterization of normal blood CD561lo versus CD561hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol. Dis. 2001. 27: 731-743.
37. Frey, M., Packianathan, N. B., Fehniger, T. A., Ross, M. E., Wang, W. C., Stewart, C. C., Caligiuri, M. A. and Evans, S. S., Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 1998. 161: 400-408. (Pubitemid 28285548)
38. Gregoire, C., Cognet, C., Chasson, L., Coupet, C. A., Dalod, M., Reboldi, A., Marvel, J. et al., Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur. J. Immunol. 2008. 38: 2076-2084.
39. Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H. and Ritz, J., Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J. Immunol. 1990. 145: 3194-3201.
40. Meiser, A., Mueller, A.,Wise, E. L., McDonagh, E. M., Petit, S. J., Saran, N., Clark, P. C. et al., The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J. Immunol. 2008. 180: 6713-6724.
41. Hodge, D. L., Schill,W. B.,Wang, J. M., Blanca, I., Reynolds, D. A., Ortaldo, J. R. and Young, H. A., IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J. Immunol. 2002. 168: 6090-6098.
42. Bernardini, G., Sciume, G., Bosisio, D., Morrone, S., Sozzani, S. and Santoni, A., CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 2008. 111: 3626-3634.
43. Huntington, N. D., Tabarias, H., Fairfax, K., Brady, J., Hayakawa, Y., Degli-Esposti, M. A., Smyth, M. J. et al., NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 2007. 178: 4764-4770. (Pubitemid 46595257)
44. Di Santo, J. P., Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur. J. Immunol. 2008. 38: 2948-2951.
45. Kasaian, M. T.,Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A. et al., IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 2002. 16: 559-569. (Pubitemid 34442580)
46. Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D. and Sugamura, K., Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 2001. 167: 1-5. (Pubitemid 32567752)
47. Habib, T., Senadheera, S., Weinberg, K. and Kaushansky, K., The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 2002. 41: 8725-8731. (Pubitemid 34743313)